Speaker illustration

Professor Joann Lindenfeld

Vanderbilt University, Nashville (United States of America)

Member of:

Heart Failure Association

Dr. Lindenfeld is the Director of the Section of Heart failure and Transplantation at Vanderbilt University Medical Center in Nashville, Tennessee. US. She was a previous President of the Heart Failure Society of America(HFSA) and was the Chair of the HFSA Heart Failure Guidelines in 2006 and 2010 and also a member of the ACC/AHA/HFSA Heart Failure Guidelines. Dr. Lindenfeld has extensive experience in the conduct of clinical trials in heart failure and has served on the steering Committees of may national and international heart failure trials. She has been a member of the Food and Drug Administration Cardiorenal panels and the Cardiac Devices panel. Her research interests include cardiorenal syndrome and the use of SGLT2 inhibitors in heart failure, vascular remodeling with left ventricular assist devices, and clinical outcomes in cardiac transplantation.

Late breaking clinical trials: acute heart failure and patients' monitoring

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Late-Breaking Science


Meet the Experts: difficult decisions in advanced heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Meet the Experts


Heart transplantation: holy grail of advanced heart failure therapies?

Event: Heart Failure 2021

Topic: Heart Transplantation

Session type: Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb